Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Perfumania Holdings, Inc. (PERF)
|
Add to portfolio |
|
|
Price: |
$1.86
| | Metrics |
OS: |
15.5
|
M
| |
-53
|
% ROE
|
Market cap: |
$28.8
|
M
| |
-8
|
% ROIC
|
Net debt:
|
$3.57
|
M
| |
|
|
EV:
|
$32.4
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($4.9)
|
M
| |
|
|
EBIT
|
($12.6)
|
M
| |
|
|
EPS |
($1.74)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Jan-28-17 | Jan-30-16 | Jan-31-15 | Feb-01-14 | Feb-02-13 | Jan-28-12 | Jan-29-11 | Jan-30-10 |
Revenues | 468.9 | 542.0 | 584.0 | 575.9 | 534.8 | 493.5 | 484.8 | 510.9 |
Revenue growth | -13.5% | -7.2% | 1.4% | 7.7% | 8.4% | 1.8% | -5.1% | 19.0% |
Cost of goods sold | 247.5 | 284.3 | 312.8 | 323.7 | 321.2 | 302.4 | 304.0 | 332.1 |
Gross profit | 221.3 | 257.6 | 271.1 | 252.2 | 213.6 | 191.1 | 180.8 | 178.8 |
Gross margin | 47.2% | 47.5% | 46.4% | 43.8% | 39.9% | 38.7% | 37.3% | 35.0% |
Selling, general and administrative | 222.4 | 249.5 | 246.7 | 240.4 | 230.1 | 167.2 | 162.2 | 164.1 |
EBITA | -7.9 | 1.5 | 17.6 | 5.4 | -28.6 | 16.6 | 9.8 | 4.9 |
EBITA margin | -1.7% | 0.3% | 3.0% | 0.9% | -5.3% | 3.4% | 2.0% | 1.0% |
Amortization of intangibles | 1.9 | 4.5 | 4.4 | 6.2 | 6.7 | 0.5 | | |
EBIT | -9.8 | -3.0 | 13.2 | -0.8 | -35.3 | 16.1 | 9.8 | 4.9 |
EBIT margin | -2.1% | -0.6% | 2.3% | -0.1% | -6.6% | 3.3% | 2.0% | 1.0% |
Pre-tax income | -23.8 | -11.2 | 3.2 | -11.6 | -57.6 | 4.8 | -6.1 | -15.6 |
Income taxes | -0.2 | 0.5 | 0.5 | 0.9 | -1.6 | 0.7 | -2.4 | 0.2 |
Tax rate | 0.8% | | 17.1% | | 2.7% | 14.8% | 38.7% | |
Net income | -23.6 | -11.7 | 2.6 | -12.5 | -56.0 | 4.1 | -3.7 | -15.8 |
Net margin | -5.0% | -2.2% | 0.5% | -2.2% | -10.5% | 0.8% | -0.8% | -3.1% |
|
Diluted EPS | ($1.53) | ($0.75) | $0.17 | ($0.81) | ($4.02) | $0.46 | ($0.42) | ($1.77) |
Shares outstanding (diluted) | 15.5 | 15.5 | 15.5 | 15.4 | 13.9 | 9.0 | 9.0 | 9.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|